 | • レポートコード：QYR2104Z0300 • 出版社/出版日：QYResearch / 2021年4月10日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、筋萎縮性側索硬化症（ALS）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（リルゾール、エダラボン（ラディカバ）、その他）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・筋萎縮性側索硬化症（ALS）治療の市場動向 ・企業の競争状況、市場シェア ・筋萎縮性側索硬化症（ALS）治療の種類別市場規模（リルゾール、エダラボン（ラディカバ）、その他） ・筋萎縮性側索硬化症（ALS）治療の用途別市場規模（病院、ドラッグストア、その他） ・筋萎縮性側索硬化症（ALS）治療の北米市場規模2016-2027（アメリカ、カナダ） ・筋萎縮性側索硬化症（ALS）治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・筋萎縮性側索硬化症（ALS）治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・筋萎縮性側索硬化症（ALS）治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・筋萎縮性側索硬化症（ALS）治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Mitsubishi Tanabe Pharma、Sanofi、Mylan Pharma、Apotex、Glemark Generics、Covis Pharma、Sun Pharma、Lunan Pharma） ・結論 |
Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig’s disease or Maladie De Charcot, it is a neurological disease that causes nerve cells to gradually break down and die.The diagnosis is based on a person’s signs and symptoms, with testing done to rule out other potential causes.
Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig’s disease or Maladie De Charcot, it is a neurological disease that causes nerve cells to gradually break down and die. According to Centers for Disease Control and Prevention (CDC), 14,000 – 15,000 Americans had ALS in 2016.
Market Analysis and Insights: Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market
The global Amyotrophic Lateral Sclerosis (ALS) Treatment market size is projected to reach US$ 439.8 million by 2026, from US$ 274.3 million in 2019, at a CAGR of 6.9% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Amyotrophic Lateral Sclerosis (ALS) Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Amyotrophic Lateral Sclerosis (ALS) Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Amyotrophic Lateral Sclerosis (ALS) Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Amyotrophic Lateral Sclerosis (ALS) Treatment market.
Global Amyotrophic Lateral Sclerosis (ALS) Treatment Scope and Market Size
Amyotrophic Lateral Sclerosis (ALS) Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Amyotrophic Lateral Sclerosis (ALS) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Riluzole
Edaravone (Radicava)
Other
Segment by Application
Hospital
Drugs Store
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Mitsubishi Tanabe Pharma
Sanofi
Mylan Pharma
Apotex
Glemark Generics
Covis Pharma
Sun Pharma
Lunan Pharma
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Riluzole
1.2.3 Edaravone (Radicava)
1.2.4 Other
1.3 Market by Application
1.3.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Perspective (2016-2027)
2.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Growth Trends by Regions
2.2.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Amyotrophic Lateral Sclerosis (ALS) Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Amyotrophic Lateral Sclerosis (ALS) Treatment Industry Dynamic
2.3.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Trends
2.3.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Drivers
2.3.3 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Challenges
2.3.4 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Amyotrophic Lateral Sclerosis (ALS) Treatment Players by Revenue
3.1.1 Global Top Amyotrophic Lateral Sclerosis (ALS) Treatment Players by Revenue (2016-2021)
3.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue
3.4 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Concentration Ratio
3.4.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue in 2020
3.5 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players Head office and Area Served
3.6 Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Product Solution and Service
3.7 Date of Enter into Amyotrophic Lateral Sclerosis (ALS) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Amyotrophic Lateral Sclerosis (ALS) Treatment Breakdown Data by Type
4.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Historic Market Size by Type (2016-2021)
4.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Forecasted Market Size by Type (2022-2027)
5 Amyotrophic Lateral Sclerosis (ALS) Treatment Breakdown Data by Application
5.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Historic Market Size by Application (2016-2021)
5.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (2016-2027)
6.2 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
6.2.1 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2016-2021)
6.2.2 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2022-2027)
6.2.3 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2016-2027)
6.3 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
6.3.1 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2016-2021)
6.3.2 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2022-2027)
6.3.3 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2016-2027)
6.4 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country
6.4.1 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2016-2021)
6.4.2 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (2016-2027)
7.2 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
7.2.1 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2016-2021)
7.2.2 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2022-2027)
7.2.3 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2016-2027)
7.3 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
7.3.1 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2016-2021)
7.3.2 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2022-2027)
7.3.3 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2016-2027)
7.4 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country
7.4.1 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2016-2021)
7.4.2 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (2016-2027)
8.2 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
8.2.1 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
8.3.1 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region
8.4.1 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (2016-2027)
9.2 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
9.2.1 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2016-2027)
9.3 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
9.3.1 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2016-2027)
9.4 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country
9.4.1 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (2016-2027)
10.2 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
10.2.1 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
10.3.1 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country
10.4.1 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Mitsubishi Tanabe Pharma
11.1.1 Mitsubishi Tanabe Pharma Company Details
11.1.2 Mitsubishi Tanabe Pharma Business Overview
11.1.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
11.1.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2016-2021)
11.1.5 Mitsubishi Tanabe Pharma Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
11.2.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2016-2021)
11.2.5 Sanofi Recent Development
11.3 Mylan Pharma
11.3.1 Mylan Pharma Company Details
11.3.2 Mylan Pharma Business Overview
11.3.3 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
11.3.4 Mylan Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2016-2021)
11.3.5 Mylan Pharma Recent Development
11.4 Apotex
11.4.1 Apotex Company Details
11.4.2 Apotex Business Overview
11.4.3 Apotex Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
11.4.4 Apotex Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2016-2021)
11.4.5 Apotex Recent Development
11.5 Glemark Generics
11.5.1 Glemark Generics Company Details
11.5.2 Glemark Generics Business Overview
11.5.3 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
11.5.4 Glemark Generics Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2016-2021)
11.5.5 Glemark Generics Recent Development
11.6 Covis Pharma
11.6.1 Covis Pharma Company Details
11.6.2 Covis Pharma Business Overview
11.6.3 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
11.6.4 Covis Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2016-2021)
11.6.5 Covis Pharma Recent Development
11.7 Sun Pharma
11.7.1 Sun Pharma Company Details
11.7.2 Sun Pharma Business Overview
11.7.3 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
11.7.4 Sun Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2016-2021)
11.7.5 Sun Pharma Recent Development
11.8 Lunan Pharma
11.8.1 Lunan Pharma Company Details
11.8.2 Lunan Pharma Business Overview
11.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
11.8.4 Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2016-2021)
11.8.5 Lunan Pharma Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Riluzole
Table 3. Key Players of Edaravone (Radicava)
Table 4. Key Players of Other
Table 5. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Regions (2016-2021)
Table 9. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Regions (2022-2027)
Table 11. Amyotrophic Lateral Sclerosis (ALS) Treatment Market Trends
Table 12. Amyotrophic Lateral Sclerosis (ALS) Treatment Market Drivers
Table 13. Amyotrophic Lateral Sclerosis (ALS) Treatment Market Challenges
Table 14. Amyotrophic Lateral Sclerosis (ALS) Treatment Market Restraints
Table 15. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Players (2016-2021)
Table 17. Global Top Amyotrophic Lateral Sclerosis (ALS) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment as of 2020)
Table 18. Ranking of Global Top Amyotrophic Lateral Sclerosis (ALS) Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Product Solution and Service
Table 22. Date of Enter into Amyotrophic Lateral Sclerosis (ALS) Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Mitsubishi Tanabe Pharma Company Details
Table 63. Mitsubishi Tanabe Pharma Business Overview
Table 64. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product
Table 65. Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2016-2021) & (US$ Million)
Table 66. Mitsubishi Tanabe Pharma Recent Development
Table 67. Sanofi Company Details
Table 68. Sanofi Business Overview
Table 69. Sanofi Amyotrophic Lateral Sclerosis (ALS) Treatment Product
Table 70. Sanofi Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2016-2021) & (US$ Million)
Table 71. Sanofi Recent Development
Table 72. Mylan Pharma Company Details
Table 73. Mylan Pharma Business Overview
Table 74. Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product
Table 75. Mylan Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2016-2021) & (US$ Million)
Table 76. Mylan Pharma Recent Development
Table 77. Apotex Company Details
Table 78. Apotex Business Overview
Table 79. Apotex Amyotrophic Lateral Sclerosis (ALS) Treatment Product
Table 80. Apotex Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2016-2021) & (US$ Million)
Table 81. Apotex Recent Development
Table 82. Glemark Generics Company Details
Table 83. Glemark Generics Business Overview
Table 84. Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Treatment Product
Table 85. Glemark Generics Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2016-2021) & (US$ Million)
Table 86. Glemark Generics Recent Development
Table 87. Covis Pharma Company Details
Table 88. Covis Pharma Business Overview
Table 89. Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product
Table 90. Covis Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2016-2021) & (US$ Million)
Table 91. Covis Pharma Recent Development
Table 92. Sun Pharma Company Details
Table 93. Sun Pharma Business Overview
Table 94. Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product
Table 95. Sun Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2016-2021) & (US$ Million)
Table 96. Sun Pharma Recent Development
Table 97. Lunan Pharma Company Details
Table 98. Lunan Pharma Business Overview
Table 99. Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2016-2021) & (US$ Million)
Table 100. Lunan Pharma Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type: 2020 VS 2027
Figure 2. Riluzole Features
Figure 3. Edaravone (Radicava) Features
Figure 4. Other Features
Figure 5. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Drugs Store Case Studies
Figure 8. Other Case Studies
Figure 9. Amyotrophic Lateral Sclerosis (ALS) Treatment Report Years Considered
Figure 10. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Regions (2022-2027)
Figure 14. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Players in 2020
Figure 15. Global Top Amyotrophic Lateral Sclerosis (ALS) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue in 2020
Figure 17. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2016-2027)
Figure 21. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2016-2027)
Figure 22. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Country (2016-2027)
Figure 23. United States Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2016-2027)
Figure 27. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2016-2027)
Figure 28. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Country (2016-2027)
Figure 29. Germany Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Region (2016-2027)
Figure 39. China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Mitsubishi Tanabe Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2016-2021)
Figure 59. Sanofi Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2016-2021)
Figure 60. Mylan Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2016-2021)
Figure 61. Apotex Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2016-2021)
Figure 62. Glemark Generics Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2016-2021)
Figure 63. Covis Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2016-2021)
Figure 64. Sun Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2016-2021)
Figure 65. Lunan Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed